These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 25607987)
1. Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L. Johnston SB; Raines RT PLoS One; 2015; 10(1):e0116898. PubMed ID: 25607987 [TBL] [Abstract][Full Text] [Related]
2. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. Campbell RB; Liu F; Ross AH J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747 [TBL] [Abstract][Full Text] [Related]
3. Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation. Wei Y; Stec B; Redfield AG; Weerapana E; Roberts MF J Biol Chem; 2015 Jan; 290(3):1592-606. PubMed ID: 25429968 [TBL] [Abstract][Full Text] [Related]
4. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812 [TBL] [Abstract][Full Text] [Related]
5. Structural Mechanisms of PTEN Regulation. Masson GR; Williams RL Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31636093 [TBL] [Abstract][Full Text] [Related]
6. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function. Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ Cells; 2019 Nov; 8(12):. PubMed ID: 31779149 [TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide phosphatases: just as important as the kinases. Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078 [TBL] [Abstract][Full Text] [Related]
8. The C-terminal tail inhibitory phosphorylation sites of PTEN regulate its intrinsic catalytic activity and the kinetics of its binding to phosphatidylinositol-4,5-bisphosphate. Chia YC; Catimel B; Lio DS; Ang CS; Peng B; Wu H; Zhu HJ; Cheng HC Arch Biochem Biophys; 2015 Dec; 587():48-60. PubMed ID: 26471078 [TBL] [Abstract][Full Text] [Related]
9. A novel class of PTEN protein in Arabidopsis displays unusual phosphoinositide phosphatase activity and efficiently binds phosphatidic acid. Pribat A; Sormani R; Rousseau-Gueutin M; Julkowska MM; Testerink C; Joubès J; Castroviejo M; Laguerre M; Meyer C; Germain V; Rothan C Biochem J; 2012 Jan; 441(1):161-71. PubMed ID: 21864294 [TBL] [Abstract][Full Text] [Related]
10. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368 [TBL] [Abstract][Full Text] [Related]
11. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Rahdar M; Inoue T; Meyer T; Zhang J; Vazquez F; Devreotes PN Proc Natl Acad Sci U S A; 2009 Jan; 106(2):480-5. PubMed ID: 19114656 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of PTEN-mediated PI(3,4,5)P3 hydrolysis on solid supported membranes. Liu C; Deb S; Ferreira VS; Xu E; Baumgart T PLoS One; 2018; 13(2):e0192667. PubMed ID: 29447222 [TBL] [Abstract][Full Text] [Related]
13. PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. Redfern RE; Redfern D; Furgason ML; Munson M; Ross AH; Gericke A Biochemistry; 2008 Feb; 47(7):2162-71. PubMed ID: 18220422 [TBL] [Abstract][Full Text] [Related]
14. Voltage-sensing phosphatase: its molecular relationship with PTEN. Okamura Y; Dixon JE Physiology (Bethesda); 2011 Feb; 26(1):6-13. PubMed ID: 21357898 [TBL] [Abstract][Full Text] [Related]
15. A mutant form of PTEN linked to autism. Redfern RE; Daou MC; Li L; Munson M; Gericke A; Ross AH Protein Sci; 2010 Oct; 19(10):1948-56. PubMed ID: 20718038 [TBL] [Abstract][Full Text] [Related]
16. [Regulation of the lipid phosphatase PTEN]. Maehama T Seikagaku; 2006 Feb; 78(2):133-7. PubMed ID: 16541805 [No Abstract] [Full Text] [Related]
17. Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. McConnachie G; Pass I; Walker SM; Downes CP Biochem J; 2003 May; 371(Pt 3):947-55. PubMed ID: 12534371 [TBL] [Abstract][Full Text] [Related]
18. PTEN, more than the AKT pathway. Blanco-Aparicio C; Renner O; Leal JF; Carnero A Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655 [TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
20. Defining the membrane-associated state of the PTEN tumor suppressor protein. Lumb CN; Sansom MS Biophys J; 2013 Feb; 104(3):613-21. PubMed ID: 23442912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]